Sedia lab supply

Ended Purchase Order Awarded Last action

Contract number
75D30118P03105
Awardee
Awarding agency
Obligated
$0

Award facts

Opportunity
  • Asante HIV-1 Solicitation · 75D30118Q69335 · Posted Aug 25, 2018
Contract value 0% obligated
$77,950.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Portland, OR 97230, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 -$77,950
Original award $77,950

About this award

This firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Sedia Biosciences Corporation, doing business as Sedia Biosciences Corp, for the provision of Asante HIV-1 Rapid Recency Assay kits. The $77,950.00 contract supports CDC disease surveillance and prevention initiatives, with the kits being delivered to the CDC's Pittsburgh, Pennsylvania facility. Sedia Biosciences Corp has previously received over $350,000 in CDC purchase orders for similar laboratory supplies and equipment. No set-aside designation was associated with this contract award.

Quick answers

Who was awarded contract 75D30118P03105?

75D30118P03105 was awarded to Sedia Biosciences Corporation by CDC Pittsburgh (Centers for Disease Control and Prevention) on August 29, 2018.

How much is contract 75D30118P03105 worth?

The government has obligated $0 on 75D30118P03105. Its current value, with exercised options, is $77,950.

Was contract 75D30118P03105 competed?

The extent of competition for 75D30118P03105 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award